# EDGAR Filing Document

**Accession Number:** 0001682584
**File Stem:** 0001415889-23-005034
**Filing Date:** 2023-3
**Character Count:** 6625
**Document Hash:** c24e654f48006d4e1554d89ae5921552
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001415889-23-005034.hdr.sgml**: 20230316

**ACCESSION NUMBER**: 0001415889-23-005034

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20230314

**FILED AS OF DATE**: 20230316

**DATE AS OF CHANGE**: 20230316

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** YOUNG TODD S.
- **CENTRAL INDEX KEY:** 0001682584

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-38661
- **FILM NUMBER:** 23740103

**MAIL ADDRESS:**
- **STREET 1:** C/O ACADIA PHARMACEUTICALS INC.
- **STREET 2:** 3611 VALLEY CENTRE DRIVE, SUITE 300
- **CITY:** SAN DIEGO
- **STATE:** CA
- **ZIP:** 92130
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Elanco Animal Health Inc
- **CENTRAL INDEX KEY:** 0001739104
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **IRS NUMBER:** 825497352
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 2500 INNOVATION WAY
- **CITY:** GREENFIELD
- **STATE:** IN
- **ZIP:** 46140
- **BUSINESS PHONE:** 877-352-6261

**MAIL ADDRESS:**
- **STREET 1:** 2500 INNOVATION WAY
- **CITY:** GREENFIELD
- **STATE:** IN
- **ZIP:** 46140

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>YOUNG TODD S.<br><sub>(Last) (First) (Middle)</sub><br>C/O ELANCO ANIMAL HEALTH INCORPORATED<br>2500 INNOVATION WAY<br><sub>(Street)</sub><br>GREENFIELD, IN 46140<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2023-03-14 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [ ] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_SEE REMARKS_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>Elanco Animal Health Inc [ ELAN ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Common Stock | 2023-03-14 |  | G |  | 118309<sup>(1)</sup> | D | $0 | 87917 | D |  |
| Common Stock | 2023-03-14 |  | G |  | 118309<sup>(1)</sup> | A | $0 | 118309 | I | By Living Trust |
| Common Stock | 2023-03-15 |  | G |  | 2000<sup>(2)</sup> | D | $0 | 116309 | I | By Living Trust |
| Common Stock | 2023-03-15 |  | G |  | 2000<sup>(2)</sup> | A | $0 | 2000 | I | As UTMA custodian for daughter |
| Common Stock | 2023-03-15 |  | G |  | 2000<sup>(3)</sup> | D | $0 | 114309 | I | By Living Trust |
| Common Stock | 2023-03-15 |  | G |  | 2000<sup>(3)</sup> | A | $0 | 2000 | I | As UTMA custodian for son |
| Common Stock |  |  |  |  |  |  |  | 6562 | I | By IRA |
| Common Stock |  |  |  |  |  |  |  | 2000 | I | By J. G. Young IRA |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |

---

### Footnotes:

(1) On March 14, 2023, the reporting person transferred 118,309 directly owned shares to a living trust, of which the insider and his spouse are trustees and beneficiaries.

(2) Reflects a transfer to the reporting person as custodian for daughter under Uniform Gift to Minors Act.

(3) Reflects a transfer to the reporting person as custodian for son under Uniform Gift to Minors Act.

**Remarks:**
Executive Vice President and Chief Financial Officer

**Signature:** /s/ Catherine S. Powell, as Attorney-in-Fact for Todd S. Young  
**Date:** 2023-03-16

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**